Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
Saved in:
| Title: | Myeloid cell heterogeneity in lung cancer: implication for immunotherapy. |
|---|---|
| Authors: | Sangaletti S; Department of Research, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, via Amadeo 42, 20133, Milano, Italy., Ferrara R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Tripodo C; Tumor Immunology Unit, University of Palermo, Palermo, Italy.; FIRC Institute of Molecular Oncology (IFOM), Milano, Italy., Garassino MC; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Colombo MP; Department of Research, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, via Amadeo 42, 20133, Milano, Italy. mariopaolo.colombo@istitutotumori.mi.it. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Sep; Vol. 70 (9), pp. 2429-2438. Date of Electronic Publication: 2021 Apr 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33797567 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Myeloid cell heterogeneity in lung cancer: implication for immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sangaletti+S%22">Sangaletti S</searchLink>; Department of Research, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, via Amadeo 42, 20133, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Ferrara+R%22">Ferrara R</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Tripodo+C%22">Tripodo C</searchLink>; Tumor Immunology Unit, University of Palermo, Palermo, Italy.; FIRC Institute of Molecular Oncology (IFOM), Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Garassino+MC%22">Garassino MC</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Colombo+MP%22">Colombo MP</searchLink>; Department of Research, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, via Amadeo 42, 20133, Milano, Italy. mariopaolo.colombo@istitutotumori.mi.it. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2021 Sep; Vol. 70 (9), pp. 2429-2438. <i>Date of Electronic Publication: </i>2021 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33797567 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-021-02916-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2429 Titles: – TitleFull: Myeloid cell heterogeneity in lung cancer: implication for immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sangaletti S – PersonEntity: Name: NameFull: Ferrara R – PersonEntity: Name: NameFull: Tripodo C – PersonEntity: Name: NameFull: Garassino MC – PersonEntity: Name: NameFull: Colombo MP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2021 Sep Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 70 – Type: issue Value: 9 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |